Article Information
History
- February 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew L. Robinson1,*,
- Agha Mirza1,
- Nicholas Gallagher2,
- Alec Boudreau1,
- Lydia Garcia1,
- Tong Yu1,
- Julie Norton2,
- Chun Huai Luo2,
- Abigail Conte3,
- Ruifeng Zhou3,
- Kim Kafka4,
- Justin Hardick1,
- David D. McManus5,
- Laura L. Gibson6,
- Andrew Pekosz3,
- Heba Mostafa2 and
- Yukari C. Manabe1
- 1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 3Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 4Clinical Research Unit, Johns Hopkins Institute for Clinical and Translational Research Baltimore, MD USA
- 5Department of Medicine, University of Massachusetts T.H. Chan Medical School, Worcester, MA USA
- 6Division of Infectious Diseases and Immunology, Departments of Medicine and Pediatrics, University of Massachusetts Medical School, Worcester, MA, USA
- ↵*Corresponding Author: Matthew Robinson, 600 N Wolfe St, Phipps 521, Baltimore, MD 21287, Phone: 443-287-2443, E-mail: mrobin85{at}jhmi.edu
Posted February 07, 2022.
Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts
